SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002030
Filing Date
2022-02-25
Accepted
2022-02-25 06:06:56
Documents
115
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bbio-20211231.htm   iXBRL 10-K 6596877
2 EX-4.3 bbio-ex4_3.htm EX-4.3 79828
3 EX-10.1 bbio-ex10_1.htm EX-10.1 725325
4 EX-10.30 bbio-ex10_30.htm EX-10.30 26691
5 EX-10.39 bbio-ex10_39.htm EX-10.39 906997
6 EX-21 bbio-ex21.htm EX-21 64431
7 EX-23.1 bbio-ex23_1.htm EX-23.1 10795
8 EX-31.1 bbio-ex31_1.htm EX-31.1 14541
9 EX-31.2 bbio-ex31_2.htm EX-31.2 12827
10 EX-32.1 bbio-ex32_1.htm EX-32.1 9331
11 EX-32.2 bbio-ex32_2.htm EX-32.2 9345
12 GRAPHIC img186147651_0.jpg GRAPHIC 101683
13 GRAPHIC img186147651_1.jpg GRAPHIC 104046
14 GRAPHIC img186147651_2.jpg GRAPHIC 41707
15 GRAPHIC img186147651_3.jpg GRAPHIC 20150
16 GRAPHIC img186147651_4.jpg GRAPHIC 44456
  Complete submission text file 0000950170-22-002030.txt   26203616

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20211231.xsd EX-101.SCH 134200
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20211231_cal.xml EX-101.CAL 106849
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20211231_pre.xml EX-101.PRE 806133
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20211231_def.xml EX-101.DEF 582710
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20211231_lab.xml EX-101.LAB 997932
109 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20211231_htm.xml XML 4971474
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38959 | Film No.: 22674206
SIC: 2834 Pharmaceutical Preparations